Publication Name	World Journal of Virology
Manuscript ID	79877
Country	India

Received	2022-09-13 11:40
Peer-Review Started	2022-09-13 11:42
To Make the First Decision
Return for Revision	2022-10-04 05:44
Revised	2022-10-15 05:43
Second Decision	2022-12-01 03:25
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-12-01 23:33
Articles in Press	2022-12-01 23:33
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-11-24 05:25
Typeset the Manuscript	2023-01-12 03:26
Publish the Manuscript Online	2023-01-18 03:45

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Biochemistry & Molecular Biology
Manuscript Type	Systematic Reviews
Article Title	COVID-19-related liver injury: Focus on genetic and drug-induced perspectives
Manuscript Source	Invited Manuscript
All Author List	Deepak Parchwani, Amit D Sonagra, Sagar Dholariya, Anita Motiani and Ragini Singh
Funding Agency and Grant Number
Corresponding Author	Sagar Dholariya, MD, Assistant Professor, Department of Biochemistry, All India Institute of Medical Sciences, Jamnagar Road, Khandheri, Rajkot 360001, India. drsagar.dholariya@gmail.com
Key Words	SARS-CoV-2; Liver injury; Genetic prospective; Drug-induced liver injury; Prognosis; COVID-19
Core Tip	Evidence highlights the multisystemic nature of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Hepatic dysfunction is the primary extrapulmonary manifestation. In addition to the direct cytopathic effect of the virus, iatrogenic causes and genetic susceptibility are also postulated in the pathogenesis of hepatic damage in SARS-CoV-2 infection. Degree of liver toxicity in terms of altered biochemical indices were consistent with severity of coronavirus disease 2019 (COVID-19) illness and hospital stay. Hence, serial monitoring of hepatic indices in COVID-19 hospitalized patients may provide useful prognostic value to make timely corrective actions to avoid clinical deterioration.
Publish Date	2023-01-18 03:45
Citation	Parchwani D, Sonagra AD, Dholariya S, Motiani A, Singh R. COVID-19-related liver injury: Focus on genetic and drug-induced perspectives. World J Virol 2023; 12(1): 53-67
URL	https://www.wjgnet.com/2220-3249/full/v12/i1/53.htm
DOI	https://dx.doi.org/10.5501/wjv.v12.i1.53

Full Article (PDF)	WJV-12-53.pdf
Full Article (Word)	WJV-12-53.docx
PRISMA 2009 Checklist	79877-PRISMA-2009-Checklist-revision.pdf
Manuscript File	79877_Auto_Edited-LM.docx
Answering Reviewers	79877-Answering reviewers.pdf
Audio Core Tip	79877-Audio core tip.mp3
Biostatistics Review Certificate	79877-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	79877-Conflict-of-interest statement.pdf
Copyright License Agreement	79877-Copyright license agreement.pdf
Peer-review Report	79877-Peer-review(s).pdf
Scientific Misconduct Check	79877-Bing-Wang JJ-2.png
Scientific Editor Work List	79877-Scientific editor work list.pdf
CrossCheck Report	79877-CrossCheck report.pdf